The field of cancer therapy is an area of intense investment that is driving drug discovery and development. This burgeoning area of research and development has yielded tremendous scientific advances. Thanks to the growing understanding of cancer biology we have seen considerable progress from chemotherapy, to pioneering drugs like Herceptin^®, to PD-1 inhibitors and even genetically engineered immune cell therapies using chimeric antigen receptor (CAR) and T-cell receptor (TCR) technologies.

Read the full story here.